06/20/2014
Federal Register Notice: FDA’s proposed collection of information, “Current Good Manufacturing Practice Regulations fo...06/20/2014
Federal Register Notice: FDA is making available a draft document entitled Guidance for Industry: Determining the Need for and Con...06/11/2014
Federal Register Notice: FDA has determined the regulatory review period for AstraZeneca’s Vandetanib is 4,009 days for exte...06/11/2014
Federal Register Notice: FDA is making available a draft guidance for industry entitled Drug Supply Chain Security Act Implementat...06/11/2014
Federal Register Notice: FDA is making available a guidance entitled Global Unique Device Identification Database (GUDID): Guidanc...06/11/2014
Federal Register Notice: FDA is making available a draft guidance for industry entitled Distributing Scientific and Medical Public...06/10/2014
Federal Register Notice: FDA’s proposed collection of information, “Guidance for Industry and Food and Drug Administra...